StonvexLoading…
StonvexCore line items from BAP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | PEN 27.47B | PEN 25.66B | PEN 20.92B | PEN 19.45B |
Operating Income | PEN 7.82B | PEN 6.85B | PEN 6.87B | PEN 5.33B |
Net Income | PEN 5.62B | PEN 4.96B | PEN 4.76B | PEN 3.67B |
EPS (Diluted) | PEN 69.09 | PEN 61.08 | PEN 58.32 | PEN 44.99 |
Total Assets | PEN 256.09B | PEN 238.84B | PEN 235.41B | PEN 243.44B |
Total Liabilities | PEN 221.11B | PEN 205.73B | PEN 205.82B | PEN 216.61B |
Cash & Equivalents | PEN 47.57B | PEN 33.92B | PEN 34.12B | PEN 39.29B |
Free Cash Flow OCF − CapEx | PEN 14.21B | PEN 3.76B | PEN -1.34B | PEN 3.87B |
Shares Outstanding | 14.95M | 14.89M | 14.85M | 14.85M |